Table 2.
Vitamin | |||
---|---|---|---|
Vitamin | Drug | Effects of Interactions | Reference |
A | Paclitaxel | Vitamin A inhibits the metabolism of paclitaxel and increases the blood concentration of paclitaxel | [71] |
B6 | Phenytoin | Decrease in blood phenytoin level | [72] |
Aluminum hydroxide | Decreased absorption of riboflavin and prolonged time for urinary excretion to reach its maximum | [73] | |
Levodopa | Accelerates levodopa degradation and reduces its migration in the brain | [74] | |
B12 | Cimetidine | Decreased absorption of vitamin B12 with intake of 1000 mg/day | [75] |
C | Iron sulfate | Iron absorption increases with concurrent intake of ≥200 mg of vitamin C | [76] |
D | Thiazide Diuretics | Hypercalcemia | [77] |
Digoxin | Hypercalcemia can lead to digitalis poisoning | [78] | |
E | Warfarin | Prolongation of prothrombin time and appearance of ecchymosis | [79] |
K | Warfarin | Decreased effect of warfarin | [80] |
Calcium | |||
Drug | Effects of Interactions | Reference | |
Aspirin | AUC and Cmax significantly decreased by approximately 30% and 28%, respectively, and disappearance speed rate of aspirin also decreased | [81] | |
Tetracycline antibiotics | Calcium and the drug bind together to form a chelate, which reduces absorption from the small intestine | [82] | |
New quinolone antibiotics | [83] | ||
Bisphosphonate osteoporosis drugs | [84] | ||
Estramustine phosphate | [85] | ||
Digoxin | Large amounts of calcium should be avoided as hypercalcemia causes digitalis toxicity | [86] | |
Alfacalcidol, rocartrol, andeldecalcitol | Promotes the absorption of calcium in the intestinal tract | [87] | |
High-fat meals | |||
Drug | Effects of Interactions | Reference | |
Cyclosporine | Significantly increased blood concentration (approximate 1.5-fold AUC increase) | [88] | |
Theophylline | Faster absorption of theophylline, significant increase in AUC | [89] | |
Griseofulvin | Significantly increased absorption of griseofulvin by approximately 120% | [90] | |
Oxycodone | Approximately 20% increase in AUC | [91] | |
Ivermectin | AUC increased to approximately 2.6 times that of fasting administration | [92] | |
Erlotinib | AUC of erlotinib almost doubled compared to fasting | [93] | |
Sirolimus | Increased tmax, Cmax, and AUC | [94] | |
Regorafenib | Decrease in Cmax and AUC of active metabolites | [95] | |
Sorafenib | Decrease in plasma concentration | [96] | |
Lenalidomide | Decrease in AUC and Cmax | [97] | |
Trametinib | Plasma trametinib AUC and Cmax of plasma trametinib were decreased by approximately 10% and 70%, respectively, compared to fasting | [98] | |
Dabrafenib | AUC and Cmax decreased by approximately 31% and 51%, respectively, compared to fasting | [99] | |
High-protein meals | |||
Drug | Effects of Interactions | Reference | |
Propranolol | 74% increase in clearance of propranolol | [100] | |
Theophylline | 32% increase in the clearance of theophylline and 26% decrease in half-life | [100] | |
Levodopa | Reduced levodopa absorption due to drug transporter competition | [101] | |
Aluminum hydroxide | Decreased antacid effect of aluminum hydroxide | [102] |
Abbreviations: Area under the curve, AUC; maximum serum concentration, Cmax.